RATING RATIONALE
04Jun2025

Aishwarya Lifesciences

Brickwork Ratings assigns the ratings for the Bank Loan Facilities of Rs. 47.66 Crs. of Aishwarya Lifesciences

Particulars
Facilities** Amount(Rs.Crs.) Tenure Rating#
Fund Based 47.66 Long Term BWR BB /Stable
Assignment
Grand Total 47.66 (Rupees Forty Seven Crores and Sixty Six lakhs Only)
#Please refer to BWR website www.brickworkratings.com for definition of the ratings
**Details of Bank Loan facilities,consolidation or instruments are provided in Annexure
RATING ACTION / OUTLOOK

Brickwork Ratings has assigned a long-term rating of BWR BB/Stable for the bank loan facilities of Rs.47.66 Cr of Aishwarya Lifesciences. 

The Rating has factored, the partner's vast experience in the pharmaceutical industry and moderate financial profile. However, going forward, the ability of the concern to increase its scale of operations and manage its working capital efficiently, prompt repayment of term loans, and improve its overall profile would be the key rating sensitivities.

The rating outlook has been assigned as "Stable" as BWR believes that Aishwarya Lifesciences business risk profile will be maintained over the medium term. The 'Stable' outlook indicates a low likelihood of rating change over the medium term, The rating outlook may be revised to 'Positive' in case the revenue and profitability margins show sustained improvement. The rating outlook may be revised to 'Negative' if the financial risk profile goes down.

KEY RATING DRIVERS

Credit Strengths:


Credit Risks:

ANALYTICAL APPROACH - Standalone

For arriving at its ratings, Brickwork Ratings has taken a Standalone approach as detailed in the Rating criteria below(hyperlinks provided at the end of this rationale). 

RATING SENSITIVITIES

Going forward, the Entity’s ability to improve the scale of operations, maintain profitability, manage its working capital efficiently, and improve its overall profile would be the key rating sensitivities.


Positive: Rating may be upgraded in case of substantial improvement in operating income and an increase in operating margin of more than 25%, or on account of any other favourable factor. 

Negative: Rating may be downgraded in case there is a decrease in operating margin of less than 10% and deterioration in the financial profile of the company, including the liquidity of the company, or on account of any unforeseen unfavourable events.

LIQUIDITY INDICATORS - Adequate

The liquidity indicators of the entity are adequate, as reflected by a current ratio of 1.29 times in FY2024. The ISCR and DSCR of the company stands at 2.23 times and 1.62 times respectively in FY23-24, which indicate that the company is generating sufficient income to comfortably meet its interest and overall debt obligations. The CPLTD stood at Rs. 2.34 crore as against the Net Cash Accruals of Rs. 7.00 crore. The entity maintained a cash and cash equivalents balance of Rs. 1.98 crore. The Tangible Net Worth of the firm stands at Rs.42.10 Cr in FY2025.

ABOUT THE ENTITY
Macro Economic Indicator Sector Industry Basic Industry
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Aishwarya Lifesciences is a partnership firm and it was established in the year 2010. Mr.Niraj Kumar Nir and Mrs.Gunjita Nir are the partners of the firm. The plant has been established to manufacture various pharmaceutical sterile formulations in the form of large and small volume parenteral. Aishwarya Lifesciences has been set up with state of art manufacturing facilities to manufacture large and small volume parenteral in different pack sizes of bottle and ampoule with latest technology.
The facility of Aishwarya Lifesciences has been approved by WHO-GMP and have CE certificate .We also manufacture parenteral preparation by employing a highly sophisticated production process; the state of art Form Fill Seal (FFS) Technology where in one continuous integrated operation, the ampoule/bottles are formed, filled and sealed.
This plant is designed to manufacture large volume parenteral: 100, 300, 500, 1000 ml bottles in LDPE plastic bottles (FFS), small volume parenteral: 2, 5, 10, 20, 25, 28 and 30 ml in plastic bottles (FFS).

KEY FINANCIAL INDICATORS (Standalone)
Key Parameters Units FY 22 - 23
(Audited - Annual)
FY 23 - 24
(Audited - Annual)
FY 24 - 25
(Provisional - Annual)
Operating Revenue Rs.Crs. 119.85 122.93 90.25
EBITDA Rs.Crs. 18.06 12.00 10.51
PAT Rs.Crs. 9.11 2.97 4.07
Tangible Net Worth Rs.Crs. 46.65 42.10 45.55
Total Debt / Tangible Net Worth Times 1.00 1.12 1.10
Current Ratio Times 1.43 1.29 1.51
KEY COVENANTS OF THE FACILITY RATED

The terms of sanction include standard covenants normally stipulated for such facilities.


STATUS OF NON-COOPERATION WITH PREVIOUS CRA

Creadit Rating AgencyStatus and Reason for Non-CooparationDate of Press Release
INDIndia Ratings has downgraded the long-term rating of Aishwarya Lifescience to IND BB-/Negative and continued the ratings under the Issuer Not Cooperating category owing to lack of adequate information and non-submission of documents to conduct a valid rating.12May2025

RATING HISTORY FOR LAST THREE YEARS (including withdrawal and suspended)
Facilities Current Rating  (2025) 2024 2023 2022
Type Tenure Amount
(Rs.Crs.)
Rating Date Rating Date Rating Date Rating
Fund Based LT 47.66
BWR BB/Stable
(Assignment)
NA
NA
NA
NA
NA
NA
Grand Total 47.66 (Rupees Forty Seven Crores and Sixty Six lakhs Only)
Hyperlink/Reference to applicable Criteria
Analytical Contacts

Gokul D

Rating Analyst gokul.d@brickworkratings.com

Sabitha M Nayak

Associate Director-Ratings sabitha.nayak@brickworkratings.com
1-860-425-2742 | media@brickworkratings.com Customer Support | CustSupport@brickwrokratings.com
Aishwarya Lifesciences
ANNEXURE-I
Details of Bank Facilities rated by BWR
SL.No. Name of the Bank/Lender Type Of Facilities Long Term(Rs.Crs.) Short Term(Rs.Crs.) Total(Rs.Crs.) Complexity of the Instrument
1 DBS Bank India Limited Cash CreditSanctioned 3.00 _ 3.00 Simple##
2 Union Bank of India Term LoanSanctioned 14.66 _ 14.66 Simple##
3 Union Bank of India Cash CreditSanctioned 30.00 _ 30.00 Simple##
Total 47.66 0.00 47.66
TOTAL (Rupees Forty Seven Crores and Sixty Six lakhs Only)

## BWR complexity levels are meant for educating investors. The BWR complexity levels are available at www.brickworkratings.com / download / ComplexityLevels.pdf. Investors queries can be sent to info@brickworkratings.com.

ANNEXURE-II
INSTRUMENT DETAILS

InstrumentIssue DateAmount (Rs.Crs)Coupon Rate (%)Maturity DateISIN ParticularsComplexity of the Instrument
NilNilNilNilNilNilNil

ANNEXURE-III
List of entities consolidated

Name of Entity% OwnershipExtent of consolidationRationale for consolidation
NilNilNilNil

Print and Digital Media

The Rating Rationale is sent to you for the sole purpose of dissemination through your print, digital or electronic media. While it may be used by you acknowledging credit to BWR, please do not change the wordings in the rationale to avoid conveying a meaning different from what was intended by BWR. BWR alone has the sole right of sharing (both direct and indirect) its rationales for consideration or otherwise through any print or electronic or digital media.

About Brickwork Ratings

Brickwork Ratings (BWR), a Securities and Exchange Board of India [SEBI] registered Credit Rating Agency and accredited by Reserve Bank of India [RBI], offers credit ratings of Bank Loan, Non- convertible / convertible / partially convertible debentures and other capital market instruments and bonds, Commercial Paper, perpetual bonds, asset-backed and mortgage-backed securities, partial guarantees and other structured / credit enhanced debt instruments, Security Receipts, Securitization Products, Municipal Bonds, etc. BWR has rated over 11,560 medium and large corporates and financial institutions’ instruments. BWR has also rated NGOs, Educational Institutions, Hospitals, Real Estate Developers, Urban Local Bodies and Municipal Corporations. BWR has Canara Bank, a leading public sector bank, as one of the promoters and strategic partner.

Disclaimer

Brickwork Ratings India Pvt. Ltd. (BWR), a Securities and Exchange Board of India [SEBI] registered Credit Rating Agency and accredited by the Reserve Bank of India [RBI], offers credit ratings of Bank Loan facilities, Non- convertible / convertible / partially convertible debentures and other capital market instruments and bonds, Commercial Paper, perpetual bonds, asset-backed and mortgage-backed securities, partial guarantees and other structured / credit enhanced debt instruments, Security Receipts, Securitization Products, Municipal Bonds, etc. [ hereafter referred to as "Instruments"]. BWR also rates NGOs, Educational Institutions, Hospitals, Real Estate Developers, Urban Local Bodies and Municipal Corporations.

BWR wishes to inform all persons who may come across Rating Rationales and Rating Reports provided by BWR that the ratings assigned by BWR are based on information obtained from the issuer of the instrument and other reliable sources, which in BWR's best judgment are considered reliable. The Rating Rationale / Rating Report & other rating communications are intended for the jurisdiction of India only. The reports should not be the sole or primary basis for any investment decision within the meaning of any law or regulation (including the laws and regulations applicable in Europe and also the USA).

BWR also wishes to inform that access or use of the said documents does not create a client relationship between the user and BWR.

The ratings assigned by BWR are only an expression of BWR's opinion on the entity / instrument and should not in any manner be construed as being a recommendation to either, purchase, hold or sell the instrument.

BWR also wishes to abundantly clarify that these ratings are not to be considered as an investment advice in any jurisdiction nor are they to be used as a basis for or as an alternative to independent financial advice and judgment obtained from the user's financial advisors. BWR shall not be liable to any losses incurred by the users of these Rating Rationales, Rating Reports or its contents. BWR reserves the right to vary, modify, suspend or withdraw the ratings at any time without assigning reasons for the same.

BWR's ratings reflect BWR's opinion on the day the ratings are published and are not reflective of factual circumstances that may have arisen on a later date. BWR is not obliged to update its opinion based on any public notification, in any form or format although BWR may disseminate its opinion and analysis when deemed fit.

Neither BWR nor its affiliates, third party providers, as well as the directors, officers, shareholders, employees or agents (collectively, "BWR Party") guarantee the accuracy, completeness or adequacy of the Ratings, and no BWR Party shall have any liability for any errors, omissions, or interruptions therein, regardless of the cause, or for the results obtained from the use of any part of the Rating Rationales or Rating Reports. Each BWR Party disclaims all express or implied warranties, including, but not limited to, any warranties of merchantability, suitability or fitness for a particular purpose or use. In no event shall any BWR Party be liable to any one for any direct, indirect, incidental, exemplary, compensatory, punitive, special or consequential damages, costs, expenses, legal fees, or losses (including, without limitation, lost income or lost profits and opportunity costs) in connection with any use of any part of the Rating Rationales and/or Rating Reports even if advised of the possibility of such damages. However, BWR or its associates may have other commercial transactions with the company/entity. BWR and its affiliates do not act as a fiduciary.

BWR keeps certain activities of its business units separate from each other in order to preserve the independence and objectivity of the respective activity. As a result, certain business units of BWR may have information that is not available to other BWR business units. BWR has established policies and procedures to maintain the confidentiality of certain non-public information received in connection with each analytical process.

BWR clarifies that it may have been paid a fee by the issuers or underwriters of the instruments, facilities, securities etc., or from obligors. BWR's public ratings and analysis are made available on its web site, www.brickworkratings.com. More detailed information may be provided for a fee. BWR's rating criteria are also generally made available without charge on BWR's website.

This disclaimer forms an integral part of the Ratings Rationales / Rating Reports or other press releases, advisories, communications issued by BWR and circulation of the ratings without this disclaimer is prohibited.

BWR is bound by the Code of Conduct for Credit Rating Agencies issued by the Securities and Exchange Board of India and is governed by the applicable regulations issued by the Securities and Exchange Board of India as amended from time to time.